# Cardiatec Biosciences (Cardiatec Biosciences Ltd)

Private limited company registered in Oakham, classed under “Research and experimental development on biotechnology”.

- Company number: 13634184
- Status: Active
- Type: Private limited company
- Incorporated: 21 September 2021
- Registered office: Ketton Suite The King Centre, Main Road, Barleythorpe, Oakham, Rutland, LE15 7WD
- Location: Oakham, Rutland
- Activity: Research and experimental development on biotechnology

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Cardiatec Biosciences do?

Private limited company registered in Oakham, classed under “Research and experimental development on biotechnology”.

### How much turnover does Cardiatec Biosciences make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/cardiatec-biosciences-13634184

### Is Cardiatec Biosciences profitable?

Cardiatec Biosciences's profit isn't public: small companies may file without a profit and loss account.

### How many people work at Cardiatec Biosciences?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/cardiatec-biosciences-13634184

### Who runs and owns Cardiatec Biosciences?

Its directors are Todd Barrett Kimmel, Raphael Peralta, Niall John Santamaria, Thelma Zablocki. Its owners are shown to subscribers.

### Where is Cardiatec Biosciences based?

Its registered office is Ketton Suite The King Centre, Main Road, Barleythorpe, Oakham, Rutland, LE15 7WD, in Oakham, Rutland.

### When was Cardiatec Biosciences founded?

Cardiatec Biosciences Ltd was incorporated on 21 September 2021.

### Is Cardiatec Biosciences still trading?

The register lists Cardiatec Biosciences Ltd as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-05-28: Resolutions (and 4 more like it since 30 June 2022)
- 2026-02-18: Total exemption full accounts made up to 31 December 2025
- 2025-06-03: Termination of appointment of Diana Rottger as a director on 31 May 2025
- 2025-03-11: Total exemption full accounts made up to 31 December 2024
- 2024-10-09: Statement of capital following an allotment of shares on 7 October 2024 · GBP 252.233 (and 9 more like it since 21 June 2022)
- 2024-07-02: Second filing for the cessation of Raphael Peralta as a person with significant control
- 2024-06-18: Second filing for the appointment of Mr Mr Todd Barrett Kimmel as a director
- 2024-06-18: Second filing of a statement of capital following an allotment of shares on 7 June 2024 · GBP 210.322
- 2024-06-12: Memorandum and Articles of Association (and 1 more like it since 23 June 2022)
- 2024-06-11: Notification of a person with significant control statement (and 2 more like it since 25 March 2022)
- 2024-06-10: Cessation of Raphael Peralta as a person with significant control on 31 May 2024
- 2024-06-05: Appointment of Mr Todd Barrett Kimmel as a director on 31 May 2024
- 2024-04-19: Cessation of Namshik Han as a person with significant control on 29 March 2024
- 2024-04-19: Cessation of Thelma Zablocki as a person with significant control on 29 March 2024
- 2024-01-30: Change of details for Ms Thelma Zablocki as a person with significant control on 22 January 2024
- 2024-01-30: Director's details changed for Ms Thelma Zablocki on 22 January 2024
- 2024-01-30: Total exemption full accounts made up to 31 December 2023
- 2023-06-22: Director's details changed for Ms Thelma Zablocki on 22 June 2023
- 2023-06-22: Change of details for Ms Thelma Zablocki as a person with significant control on 22 June 2023
- 2023-04-14: Change of details for Mr Namshik Han as a person with significant control on 1 April 2023
- 2023-02-09: Total exemption full accounts made up to 31 December 2022
- 2022-08-12: Current accounting period extended from 30 September 2022 to 31 December 2022
- 2022-06-28: Appointment of Mr Niall John Santamaria as a director on 24 June 2022
- 2022-06-28: Appointment of Ms Diana Rottger as a director on 24 June 2022
- 2022-06-22: Appointment of Ms Thelma Zablocki as a director on 20 May 2022

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/cardiatec-biosciences-13634184